Now in its 37th successful year, the conference will be exploring topics including keeping pace with developments in digital health and AI to countering the emerging competitors in the healthcare space, and reinventing the business model for the age of the patient.
Over two days delegates have the opportunity to debate on burning issues in the industry, learn from top executives and visionaries who are driving the industry, and network with key decision makers for future business opportunities and collaboration.
Further information on this year's agenda and speaker line up will be announced soon.
For sponsorship / exhibition enquiries, please contact Joe Hames via email: joe.hames@ft.com
Price
Early Bird Ticket Offer - ends on 3rd March: GBP 1799.0
Artists / Speakers: Kåre Schultz, President and CEO, Teva, Heather Bresch, Chief Executive Officer, Mylan, Chair: Sarah Neville, Global Pharmaceuticals Editor, Financial Times, More speakers to be announced soon
Over two days delegates have the opportunity to debate on burning issues in the industry, learn from top executives and visionaries who are driving the industry, and network with key decision makers for future business opportunities and collaboration.
Further information on this year's agenda and speaker line up will be announced soon.
For sponsorship / exhibition enquiries, please contact Joe Hames via email: joe.hames@ft.com
Price
Early Bird Ticket Offer - ends on 3rd March: GBP 1799.0
Artists / Speakers: Kåre Schultz, President and CEO, Teva, Heather Bresch, Chief Executive Officer, Mylan, Chair: Sarah Neville, Global Pharmaceuticals Editor, Financial Times, More speakers to be announced soon
